Key result
Brain metastases were associated with significantly worse overall survival compared to bone metastases in patients with primary malignant cardiac tumors (HR 3.20).
Why the study?
Distant metastases are independent negative prognostic factors for primary malignant cardiac tumors, but metastatic patterns and their prognostic effects required further investigation.
Cohort (n=218)
Yes
Hazard Ratio: 3.2 (95% CI 1.02–10)
p-value: p=0.046
In patients with primary malignant cardiac tumors, sarcoma histology and tumor size >4 cm are independent risk factors for distant metastases, with lung being the most common site and brain metastases conferring the worst survival.
Sarcoma histology and tumors >4 cm may flag higher metastatic risk in PMCT; leaves open prospective validation of surveillance and therapy.
Background Distant metastases are independent negative prognostic factors for patients with primary malignant cardiac tumors (PMCT). This study aims to further investigate metastatic patterns and their prognostic effects in patients with PMCT. Materials and methods This multicenter retrospective study included 218 patients with PMCT diagnosed between 2010 and 2017 from Surveillance, Epidemiology, and End Results (SEER) database. Logistic regression was utilized to identify metastatic risk factors. A Chi-square test was performed to assess the metastatic rate. Kaplan–Meier methods and Cox regression analysis were used to analyze the prognostic effects of metastatic patterns. Results Sarcoma ( p = 0.002) and tumor size¿4 cm ( p = 0.006) were independent risk factors of distant metastases in patients with PMCT. Single lung metastasis (about 34%) was the most common of all metastatic patterns, and lung metastases occurred more frequently (17.9%) than bone, liver, and brain. Brain metastases had worst overall survival (OS) and cancer-specific survival (CSS) among other metastases, like lung, bone, liver, and brain (OS: HR = 3.20, 95% CI: 1.02–10.00, p = 0.046; CSS: HR = 3.53, 95% CI: 1.09–11.47, p = 0.036). Conclusion Patients with PMCT who had sarcoma or a tumor larger than 4 cm had a higher risk of distant metastases. Lung was the most common metastatic site, and brain metastases had worst survival among others, such as lung, bone, liver, and brain. The results of this study provide insight for early detection, diagnosis, and treatment of distant metastases associated with PMCT.
No takes yet. Share an insight, caveat, or question.
Guan et al. (2022) conducted a cohort in Primary malignant cardiac tumor (n=218). Brain metastases vs. Bone metastases was evaluated on Overall survival (HR 3.20, 95% CI 1.02-10.00, p=0.046). Brain metastases were associated with significantly worse overall survival compared to bone metastases in patients with primary malignant cardiac tumors (HR 3.20).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: